We are live on ! Find out more
EWA

Evolution Wealth Advisors Portfolio holdings

AUM $855M
1-Year Est. Return 27.24%
This Fund
S&P 500
This Quarter Est. Return
+3.12%
1 Year Est. Return
+27.24%
3 Year Est. Return
+84.49%
5 Year Est. Return
+57.17%
10 Year Est. Return
AUM
$231M
AUM Growth
+$13.9M
Cap. Flow
+$936K
Cap. Flow %
0.4%
Top 10 Hldgs %
74.73%
Holding
495
New
390
Increased
42
Reduced
20
Closed
28

Sector Composition

Rank Sector Weight
1 Miscellaneous 68.22%
2 Financials 15.84%
3 Materials 5.29%
4 Consumer Discretionary 4.18%
5 Technology 2.08%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
RNG icon
76
RingCentral
RNG
$6.13B
$61K 0.03%
533
-110
-17% -$12.7K
DBX icon
77
Dropbox
DBX
$7.57B
$59K 0.03%
2,355
-2,019
-46% -$46.6K
ABBV icon
78
AbbVie
ABBV
$453B
$57K 0.02%
+788
New +$61.9K
ELV icon
79
Elevance Health
ELV
$88.4B
$55K 0.02%
+195
New +$53.3K
XAR icon
80
State Street SPDR S&P Aerospace & Defense ETF
XAR
$5.77B
$55K 0.02%
525
-75
-13% -$7.32K
BSX icon
81
Boston Scientific
BSX
$69.3B
$54K 0.02%
+1,250
New +$48.1K
DBJP icon
82
Xtrackers MSCI Japan Hedged Equity ETF
DBJP
$722M
$53K 0.02%
1,380
+80
+6% +$3.15K
TWO
83
DELISTED
Two Harbors Investment
TWO
$51K 0.02%
1,000
AZN icon
84
AstraZeneca
AZN
$252B
$50K 0.02%
+611
New +$47.9K
BMY icon
85
Bristol-Myers Squibb
BMY
$136B
$50K 0.02%
+1,096
New +$51.1K
GE icon
86
GE Aerospace
GE
$350B
$50K 0.02%
959
+257
+37% +$12.7K
GILD icon
87
Gilead Sciences
GILD
$187B
$46K 0.02%
+676
New +$44.5K
HUM icon
88
Humana
HUM
$48.2B
$46K 0.02%
+175
New +$44.4K
TAK icon
89
Takeda Pharmaceutical
TAK
$58.9B
$46K 0.02%
+2,611
New +$47.5K
XOM icon
90
ExxonMobil
XOM
$656B
$45K 0.02%
+588
New +$45.5K
CELG
91
DELISTED
Celgene Corp
CELG
$45K 0.02%
+490
New +$46.5K
NBIX icon
92
Neurocrine Biosciences
NBIX
$15.8B
$40K 0.02%
+476
New +$39.1K
SNY icon
93
Sanofi
SNY
$106B
$40K 0.02%
+933
New +$39.7K
TEF
94
DELISTED
Telefonica
TEF
$38K 0.02%
+5,631
New +$37.4K
COO icon
95
Cooper Companies
COO
$13.6B
$34K 0.01%
+404
New +$30.4K
CVX icon
96
Chevron
CVX
$409B
$34K 0.01%
+270
New +$32.6K
PFE icon
97
Pfizer
PFE
$162B
$34K 0.01%
+832
New +$33K
CSCO icon
98
Cisco
CSCO
$431B
$33K 0.01%
+599
New +$33.1K
JOF
99
Japan Smaller Capitalization Fund
JOF
$363M
$33K 0.01%
+3,900
New +$33.4K
OIH icon
100
VanEck Oil Services ETF
OIH
$1.97B
$33K 0.01%
110

Similar funds

Evolution Wealth Advisors's Q2 2019 Portfolio in Review

As of Q2 2019, Evolution Wealth Advisors held 495 positions worth $231M, up 6.4% from $218M the previous quarter. Its ten largest holdings account for 75% of the portfolio.

Evolution Wealth Advisors's Q2 2019 filing shows 390 new, 42 increased, 20 reduced and 28 closed positions. Its largest new stake was Bank of America: 714,225 shares worth $27.6M. The largest sale was Vanguard Morningstar Value ETF, an estimated $11.7M.

By sector, the portfolio is most concentrated in Miscellaneous at 68% of assets, down from 90% a quarter earlier, followed by Financials and Materials.

  • Evolution Wealth Advisors's largest Q2 2019 buy was Bank of America: 714,225 shares worth $27.6M.
  • Evolution Wealth Advisors added most to State Street SPDR S&P 500 ETF Trust in Q2 2019, an estimated $7.19M increase.
  • Evolution Wealth Advisors's biggest Q2 2019 reduction was Invesco S&P 500 High Dividend Low Volatility ETF, cutting an estimated $684K.
  • Evolution Wealth Advisors fully exited Vanguard Morningstar Value ETF in Q2 2019, selling an estimated $11.7M.
  • Evolution Wealth Advisors's ten largest holdings make up 75% of its $231M portfolio in Q2 2019.
  • Evolution Wealth Advisors opened 390 new positions and closed 28 in Q2 2019.
  • Evolution Wealth Advisors's portfolio value rose 6.4% quarter-over-quarter to $231M.

Based on Evolution Wealth Advisors's 13F filing for Q2 2019, filed 12 Jul 2019.